논문KCI 등재
Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (15)
- Yang T, "Hepatocellular carcinoma in China", BMJ (Clinical research ed.), 340, pp.c1026~ (2010)
- Yang T, "Liver disease in China : A long way to go", Hepatology, 62, pp.1640~ (2015)
- Diyang Xie, "Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective", Clinical and Molecular Hepatology, 29(2), pp.206~216 (2023), 대한간학회
- Fan R, "aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis", J Hepatol, 73, pp.1368~1378 (2020)
- Zhou J, "Guidelines for diagnosis and treatment of primary liver cancer in China(2017 Edition)", Liver Cancer, 7, pp.235~260 (2018)
- Park JW, "Global patterns of hepatocellular carcinoma management from diagnosis to death : the BRIDGE Study", Liver Int, 35, pp.2155~2166 (2015)
- Jaffe A, "Holistic management of hepatocellular carcinoma : The hepatologist’s comprehensive playbook", Liver Int, 42, pp.2607~2619 (2022)
- Lurje I, "Treatment strategies for hepatocellular carcinoma-a multidisciplinary approach", Int J Mol Sci, 20, pp.1465~ (2019)
- Naugler WE, "Building the multidisciplinary team for management of patients with hepatocellular carcinoma", Clin Gastroenterol Hepatol, 13, pp.827~835 (2015)
- Han J, "Challenge of China’s rural health", BMJ, 353, pp.i2003~ (2016)
- Zhong JH, "Controversies and evidence of hepatic resection for hepatocellular carcinoma", BBA Clin, 6, pp.125~130 (2016)
- Yang T, "Comparison of patterns and outcomes of liver resection for hepatocellular carcinoma : East vs West", Clin Gastroenterol Hepatol, 15, pp.1972~1974 (2017)
- Yang T, "Expanded criteria for resection : Are current guidelines too conservative", Curr Hepatology Rep, 15, pp.323~326 (2016)
- Giannini EG, "Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice", Hepatology, 67, pp.1784~1796 (2018)
- Wu H, "Real-world role of performance status in surgical resection for hepatocellular carcinoma : A multicenter study", Eur J Surg Oncol, 45, pp.2360~2368 (2019)
관련 논문AI추천
The clinical management of hepatocellular carcinoma in China: Progress and challengesJidong Jia, Shan Shan대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparisonBo Hyun Kim, Joong-Won Park, Yuri Cho대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma김도영대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspectiveDiyang Xie, Jia Fan, Jian Zhou, Jieyi Shi, Qiang Gao대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Urgent need for education on hepatocellular carcinoma surveillance among high-risk population in ChinaChao Li, Lei Cai, Li-Yang Sun, Ming-Da Wang, Tian Yang, Yong-Kang Diao대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in TaiwanSan-Chi Chen대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호
이 간행물의 다른 논문 (53건)
Congratulatory remarksSi Hyun Baepp. 1-1Special thanksSeung Up Kimpp. 4-4MAFLD: How is it different from NAFLD?Ming-Hua Zheng, Jacob George, Cameron Gofton, Yadhavan Upendranpp. 17-31Global incidence and prevalence of nonalcoholic fatty liver diseaseEunice Tan, Mark D. Muthiah, Cheng Han Ng, Margaret LP Teng, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Daniel Q. Huangpp. 32-42Nonalcoholic fatty liver disease and non-liver comorbiditiesRichie Manikat, Mindie H. Nguyenpp. 86-102
